Company / Current Assets per Share
Cue Biopharma, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.60
FY2025
5-year range
$0.53 / $2.40
FY2021-FY2025
Trend
+12.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $0.60.
Based on SEC 10-K filings.
0.60 in FY2025 with a 5-year CAGR of -28.9%.
Declined from $1.09 to $0.60 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -37.0%
- 5-Year CAGR
- -28.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share increased 12.4% year-over-year.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.60 | +12.4% |
| FY2024 | $0.53 | -51.1% |
| FY2023 | $1.09 | -54.5% |
| FY2022 | $2.40 | +6.3% |
| FY2021 | $2.26 | -31.5% |
| FY2020 | $3.30 | +11.8% |
| FY2019 | $2.95 | +41.3% |
| FY2018 | $2.09 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026